Part I. Preparation of Cell and Tissue Samples
Breast Tissue Banking: Collection, Handling, Storage, and Release of Tissue for Breast Cancer Research
Linda Snell and Peter H. Watson
Frozen Biopsy Collection and Storage: Frozen Biopsy Samples
Russell Leek
Serial Biopsies/Fine-Needle Aspirates and Their Assessment
Irene Boeddinghaus and Stephen R. D. Johnson
Breast Tissue Microarrays
Robert J. Springall and Cheryl E. Gillett
Preparation of Tumor Homogenates for Subsequent Preparation of Cytosols, Membrane Fractions, RNA, and DNA
Naomi Robertson and Russell Leek
Isolation of RNA From Tumor Samples: Single-Step Guanidinium Acid-Phenol Method
Naomi Robertson and Russell Leek
Isolation of DNA From Tumor Samples
Naomi Robertson and Russell Leek
Laser-Assisted Microdissection and Isolation of DNA and RNA
Ulrich Lehmann and Hans Kreipe
Part II. Markers of Clinical Outcome and Prognosis
Traditional and Established Indicators of Prognosis and Treatment Success
Derek E. Roskell and Ian D. Buley
Sentinel Lymph Node Biopsy in Breast Cancer
Celia Chao and Kelly M. McMasters
Pathological Evaluation of Axillary Sentinel Lymph Nodes in Breast Cancer
Michael Z. Gilcrease and Aysegul Sahin
Measurement of Estrogen Receptor Status by Immunocytochemistry in Paraffin Wax Sections
Bharat Jasani, Anthony Douglas-Jones, Anthony Rhodes, Susan Wozniak, Peter J. Barrett-Lee, Julia Gee, and Robert Nicholson
Markers of Apoptosis
Fazlul H. Sarkar and Yiwei Li
Quantitative Angiogenesis in Breast Cancer
Stephen B. Fox
Part III. Analysis of Tumor-Derived Proteins and Antigens
Immunohistochemistry
Cheryl E. Gillett
Detection of Aberrant Glycosylation in Breast Cancer Using Lectin Histochemistry
Tracey M. Carter and Susan A. Brooks
SDS-PAGE and Western Blotting to Detect Proteins and Glycoproteins of Interest in Breast Cancer Research
Chloe Osborne and Susan A. Brooks
Breast Cancer Proteomics Using Two-Dimensional Electrophoresis: Studying the Breast Cancer Proteome
Miriam V. Dwek and Sarah L. Rawlings
Procedures for the Quantitative Protein Determination of Urokinase and Its Inhibitor, PAI-1, in Human Breast Cancer Tissue Extracts by ELISA
Manfred Schmitt, Alexandra S. Sturmheit, Anita Welk, Christel Schnelldorfer, and Nadia Harbeck
Part IV. Analysis of Genes and Gene Expression in Tumor Specimens
Fluorescence In Situ Hybridization and Comparative Genomic Hybridization
Patricia Gorman and Rebecca Roylance
Fluorescence In Situ Hybridization Assessment of c-myc Gene Amplification in Breast Tumor Tissues
Jan K. Blancato, Mary Steele Williams, and Robert B. Dickson
Detection of HER2 Gene Amplification by Fluorescence In Situ Hybridization in Breast Cancer
John M. S. Bartlett and Amanda Forsyth
In Situ Hybridization Combined With Immunohistochemistry to Localize Gene Expression
Rosemary Jeffery, Toby Hunt, and Richard Poulsom
Quantitation of RNA by Ribonuclease Protection Assay
John W. Moore
Identification of Steroid Hormone-Regulated Genes in Breast Cancer
Bruce R. Westley and Felicity E. B. May
Sequencing of the Tumor Suppressor Gene TP 53
Barbro Linderholm, Torbjörn Norberg, and Jonas Bergh
Expression Profiling Using cDNA Microarrays
Chris Jones, Peter Simpson, Alan Mackay, and Sunil R. Lakhani
Gene Expression Analysis Using Filter cDNA Microarrays
Peter Simpson, Chris Jones, Alan Mackay, and Sunil R. Lakhani
Part V. Studying Cancer Cell Behavior In Vitro and In Vivo
Methods to Analyze the Effects of the Urokinase System on Cancer Cell Adhesion, Proliferation, Migration,